Amphastar Pharmaceuticals
AMPH
AMPH
135 hedge funds and large institutions have $591M invested in Amphastar Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 9 closing their positions.
Holders
135
Holders Change
+24
Holders Change %
+21.62%
% of All Funds
2.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
43
Reduced
38
Closed
9
Calls
–
Puts
$2.36M
Net Calls
-$2.36M
Net Calls Change
-$2.2M
Top Buyers
| 1 |
1
Fuller & Thaler Asset Management
San Mateo,
California
|
$18.3M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$28.5M |
| 3 |
3
BlackRock
New York
|
$149M |
| 4 |
4
Nordea Investment Management
Stockholm,
Sweden
|
$11.8M |
| 5 |
5
Wells Fargo
San Francisco,
California
|
$5.25M |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$11.5M |
| 2 |
2
Marshall Wace
London,
United Kingdom
|
$2.97M |
| 3 |
3
Goldman Sachs
New York
|
$9.76M |
| 4 |
4
Morgan Stanley
New York
|
$2.75M |
| 5 |
5
VOYA Investment Management
Atlanta,
Georgia
|
$9.64M |
